台股 » 個股 » 智基 » 籌碼相關 » 券商分點績效

智基

(6294)
可現股當沖
  • 股價
    102.5
  • 漲跌
    --
  • 漲幅
    0.00%
  • 成交量
    26
  • 產業
    上櫃 文化創意指數
  • 106人加入追蹤

    立即追蹤

  • 本地時間:13:30(已收盤)

     
智基 (6294)籌碼相關-券商分點績效/獲利分析
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

«前一日     2024/04/25     後一日»

券商獲利排行 - 2024/04/25

券商分點績效總損益(仟)己實現(仟)未實現(仟)買賣超買張賣張均價均買均賣現價
  12.49%292.50292.5-20020117.10117.1102.5
  12.39%58058-4041170117102.5
  12.77%45045-303117.50117.5102.5
  12.77%30030-202117.50117.5102.5
  12.77%30030-202117.50117.5102.5
  13.14%15.5015.5-1011180118102.5
  12.77%15015-101117.50117.5102.5
  12.77%15015-101117.50117.5102.5
  12.77%15015-101117.50117.5102.5
  12.77%15015-101117.50117.5102.5
  12.77%15015-101117.50117.5102.5
  12.77%15015-101117.50117.5102.5
  0.43%0.50.50011117.3117117.5102.5
  0.37%0.40.40011117.3117.1117.5102.5
   000000118.50118.5102.5
   0000001180118102.5
   000000117.5117.50102.5
   000000117.5117.50102.5
   0000001181180102.5
   0000001181180102.5
   0000001181180102.5
   000000117.50117.5102.5
   0000001180118102.5
   0000001180118102.5
   0000001181180102.5
   000000117.5117.50102.5
   0000001181180102.5
   000000117.50117.5102.5
   0000001181180102.5
   000000117.5117.50102.5
   0000001181180102.5
   0000001181180102.5
   000000117.5118.5117.5102.5
   0000001181180102.5
   000000118118118102.5
   000000117.70117.7102.5
  -12.39%-14.50-14.5010117117117.5102.5
  -12.39%-14.50-14.51101171170102.5
  -12.39%-14.50-14.51101171170102.5
  -12.39%-14.50-14.51101171170102.5
  -12.77%-150-15110117.5117.50102.5
  -12.77%-150-15110117.5117.50102.5
  -12.77%-150-15110117.5117.50102.5
  -12.77%-150-15110117.5117.50102.5
  -12.77%-150-15110117.5117.50102.5
  -12.77%-150-15110117.5117.50102.5
  -12.77%-150-15110117.5117.50102.5
  -6.38%-150-15121117.5117.5117.5102.5
  -12.77%-150-15110117.5117.50102.5
  -12.77%-150-15110117.5117.50102.5

券商虧損排行 - 2024/04/25

券商分點績效總損益(仟)己實現(仟)未實現(仟)買賣超買張賣張均價均買均賣現價
  -12.69%-74.50-74.5550117.4117.40102.5
  -12.54%-73.50-73.5550117.2117.20102.5
  -12.49%-58.50-58.5440117.1117.10102.5
  -12.39%-43.50-43.53301171170102.5
  -12.39%-43.50-43.53301171170102.5
  -8.51%-300-30231117.5117.5117.5102.5
  -13.14%-15.50-15.51101181180102.5
  -12.82%-15.10-15.1110117.6117.60102.5
  -12.77%-150-15110117.5117.50102.5
  -12.77%-150-15110117.5117.50102.5
  -12.77%-150-15110117.5117.50102.5
  -12.77%-150-15110117.5117.50102.5
  -12.77%-150-15110117.5117.50102.5
  -12.77%-150-15110117.5117.50102.5
  -12.77%-150-15110117.5117.50102.5
  -12.77%-150-15110117.5117.50102.5
  -6.38%-150-15121117.5117.5117.5102.5
  -12.77%-150-15110117.5117.50102.5
  -12.39%-14.50-14.5010117117117.5102.5
  -12.39%-14.50-14.51101171170102.5
  -12.39%-14.50-14.51101171170102.5
  -12.39%-14.50-14.51101171170102.5
   000000118.50118.5102.5
   000000117.5117.50102.5
   0000001180118102.5
   0000001180118102.5
   0000001181180102.5
   0000001181180102.5
   000000117.50117.5102.5
   0000001180118102.5
   000000117.5117.50102.5
   0000001181180102.5
   000000117.5117.50102.5
   0000001181180102.5
   000000117.70117.7102.5
   000000117.50117.5102.5
   0000001181180102.5
   0000001181180102.5
   000000118118118102.5
   0000001181180102.5
   000000117.5118.5117.5102.5
   000000117.5117.50102.5
   0000001181180102.5
   0000001181180102.5
  0.37%0.40.40011117.3117.1117.5102.5
  0.43%0.50.50011117.3117117.5102.5
  12.77%15015-101117.50117.5102.5
  12.77%15015-101117.50117.5102.5
  12.77%15015-101117.50117.5102.5
  12.77%15015-101117.50117.5102.5
慧智基因前列腺癌基因檢測套組 推行至國內千名患者Anue鉅亨-2021/09/14
疫情推升醫材需求強 雃博5月營收創同期高 慧智基因寫新猷Anue鉅亨-2021/06/10
智基 相關文章
智基 相關影音